| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ADP-, PAF- and adrenaline-induced platelet aggregation and thromboxane formation are not affected by a thromboxane receptor antagonist at physiological external Ca++ concentrations
|
Bretschneider, Ellen
|
|
1994
|
75 |
3 |
p. 233-242
10 p.
|
artikel
|
| 2 |
A garlic derivative, ajoene, inhibits platelet deposition on severely damaged vessel wall in an in vivo porcine experimental model
|
Apitz-Castro, Rafael
|
|
1994
|
75 |
3 |
p. 243-249
7 p.
|
artikel
|
| 3 |
Amino acid substitutions of the P2 residue of human antithrombin that either enhance or impair function
|
Sheffield, William P.
|
|
1994
|
75 |
3 |
p. 293-305
13 p.
|
artikel
|
| 4 |
Bleeding times related to serum triglyceride levels in healthy young adults
|
Mundal, Håvard H.
|
|
1994
|
75 |
3 |
p. 285-291
7 p.
|
artikel
|
| 5 |
Coagulation, fibrinolysis and haemorheology in premenopausal obese women with different body fat distribution
|
Avellone, Gino
|
|
1994
|
75 |
3 |
p. 223-231
9 p.
|
artikel
|
| 6 |
Degradation of the α-chain of fibrin by human neutrophil elastase reduces the stimulating effect of fibrin on plasminogen activation
|
Bach-Gansmo, Edvin T.
|
|
1994
|
75 |
3 |
p. 307-317
11 p.
|
artikel
|
| 7 |
Fibrin deposition and fibrin degradation products in atherosclerotic plaques
|
Smith, Elspeth B
|
|
1994
|
75 |
3 |
p. 329-335
7 p.
|
artikel
|
| 8 |
Fibrinogen and fibrin in the arterial wall
|
Bini, Alessandra
|
|
1994
|
75 |
3 |
p. 337-341
5 p.
|
artikel
|
| 9 |
Fibrinogen, a vascular risk factor: A simple marker or a real cause of vascular lesion?
|
Vasse, Marc
|
|
1994
|
75 |
3 |
p. 349-352
4 p.
|
artikel
|
| 10 |
Fibrinogen structure, activation, polymerization and fibrin gel structure
|
Blombäck, Birger
|
|
1994
|
75 |
3 |
p. 327-328
2 p.
|
artikel
|
| 11 |
How does ticlopidine treatment lower plasma fibrinogen?
|
Mazoyer, E.
|
|
1994
|
75 |
3 |
p. 361-370
10 p.
|
artikel
|
| 12 |
Inhibition of human platelet aggregation by GR91669, a prototype fibrinogen receptor antagonist
|
Foster, Martyn R.
|
|
1994
|
75 |
3 |
p. 269-284
16 p.
|
artikel
|
| 13 |
Inter-individual variations of the effect of low dose aspirin regime on platelet cyclooxygenase activity
|
Beving, H.
|
|
1994
|
75 |
3 |
p. 323-
1 p.
|
artikel
|
| 14 |
Pharmacological approaches of fibrin gel architecture modulation and thrombus degradation: Its implication in atherogenesis and thromboembolism disease
|
Collet, Jean-Philippe
|
|
1994
|
75 |
3 |
p. 353-359
7 p.
|
artikel
|
| 15 |
Plasma fibronectin and estrogen replacement therapy
|
Saleh, Abdelaziz A.
|
|
1994
|
75 |
3 |
p. 319-322
4 p.
|
artikel
|
| 16 |
Platelet aggregability in relation to the anaerobic threshold
|
Chicharro, JoséL.
|
|
1994
|
75 |
3 |
p. 251-257
7 p.
|
artikel
|
| 17 |
Proceedings of the IVS workshop held in Paris 17 December 1993 on “Fibrinogen, a vascular risk factor”
|
Caen, Jacques
|
|
1994
|
75 |
3 |
p. 325-326
2 p.
|
artikel
|
| 18 |
Sites in fibrin involved in the acceleration of plasminogen activation by t-PA. Possible role of fibrin polymerisation
|
Nieuwenhuizen, Willem
|
|
1994
|
75 |
3 |
p. 343-347
5 p.
|
artikel
|
| 19 |
The low pH stability of human coagulation factor XII (hageman factor) is due to reversible conformational transitions
|
Samuel, Mathew
|
|
1994
|
75 |
3 |
p. 259-268
10 p.
|
artikel
|
Tijdschrift beschrijving